Filter
5066
Filtered Results: 5066
Text search:
HIV
response
Featured
Recommendations
445
New Publications
1448
Language
Document type
No document type
3258
Studies & Reports
697
Guidelines
549
Manuals
181
Strategic & Response Plan
155
Fact sheets
86
Training Material
60
Situation Updates
33
Infographics
25
Resource Platforms
14
Brochures
7
Online Courses
1
Countries / Regions
India
214
Kenya
195
South Africa
149
Global
145
Ethiopia
123
Malawi
116
Zambia
112
Uganda
111
Nigeria
108
Tanzania
100
Liberia
97
Sierra Leone
93
Nepal
89
Western and Central Europe
83
Rwanda
78
Myanmar / Burma
74
Bangladesh
69
Africa
68
Ghana
66
Ukraine
64
Zimbabwe
62
Lesotho
61
Latin America and the Carribbean
61
Namibia
59
Mozambique
50
Eastern Europe
45
Philippines
40
Asia
40
Indonesia
39
Cambodia
35
Congo, Democratic Republic of
32
Senegal
31
Brazil
31
South–East Asia Region
29
South Sudan
28
Russia
28
Venezuela
27
Eswatini/ Swaziland
26
Botswana
26
Haiti
25
Syria
25
East and Southern Africa
24
Guinea
23
Burkina Faso
20
West and Central Africa
18
Germany
17
Argentina
16
Colombia
16
Middle East and North Africa
16
Pakistan
14
Cameroon
13
Albania
13
Tajikistan
13
Paraguay
12
Vietnam
12
Central African Republic
11
Georgia
11
Somalia
10
Angola
10
Eastern Europe and Central Asia
10
Jordan
9
Yemen
9
Sudan
8
North Macedonia
8
Bolivia
8
Moldova
8
Lebanon
7
Thailand
7
Papua New Guinea
7
Peru
7
Southern Africa
7
Afghanistan
6
Laos
6
Turkey
5
Burundi
5
Madagascar
5
Armenia
5
Portugal
5
USA
4
Iraq
4
El Salvador
4
Chile
4
Western Pacific Region
4
Iran
4
Mali
3
Guinea-Bissau
3
Niger
3
China
3
Benin
3
Serbia
3
Hungary
3
Mexico
3
Sri Lanka
3
Poland
3
Uzbekistan
3
Jamaica
3
Japan
3
United Kingdom
3
Morocco
2
Saudi Arabia
2
Egypt
2
Gambia
2
Honduras
2
Ecuador
2
Greece
2
Bhutan
2
Timor Leste/ East Timor
2
Qatar
2
Bulgaria
2
Estonia
2
Romania
2
Kyrgyzstan
2
North America
2
Turkmenistan
2
Mauritius
2
Spain
2
Côte d’Ivoire / Ivory Coast
1
Togo
1
Chad
1
Singapore
1
Switzerland
1
Croatia
1
Libya
1
Other region
1
Palestine
1
Djibouti
1
Canada
1
Slovakia
1
Kazakhstan
1
Gabon
1
Belgium
1
France
1
Tunisia
1
Norway
1
Azerbaijan
1
Belarus
1
Israel
1
Bosnia and Herzegovina
1
Authors & Publishers
Publication Years
Category
Countries
2158
Clinical Guidelines
387
Women & Child Health
275
Public Health
190
Key Resources
148
Capacity Building
103
Pharmacy & Technologies
39
Annual Report MEDBOX
3
Toolboxes
HIV
864
TB
448
COVID-19
326
Mental Health
217
AMR
123
Caregiver
118
Ebola
105
Conflict
104
Rapid Response
81
Disability
80
NTDs
72
Refugee
65
Global Health Education
62
Pharmacy
59
Planetary Health
52
Health Financing Toolbox
52
NCDs
45
Natural Hazards
42
Cholera
30
Polio
20
Zika
17
Social Ethics
12
Specific Hazards
6
South Sudan
1
Typhoon
1
2014
Addendum to meeting report: Regional consultation on HIV epidemiologic information in Latin America and the Caribbean
Module 1
Clinical
July 2017
Module 1: Clinical. This module is for clinicians, including physicians, nurses and clinical officers. It gives an overview of how to provide PrEP safely and effectively, including: screening for substantial risk of HIV<...
Module 3
Counsellors
July 2017
Module 3: Counsellors. This module is for staff who counsel people as they consider PrEP or start taking PrEP and support them in coping with side-effects and adherence strategies. Those who counsel PrEP users may be lay, peer or professional counsellors and hea...
Module 6
Pharmacists
July 2017
Module 6: Pharmacists. This module is for pharmacists and people working in pharmacies. It provides information on the medicines used in PrEP, including on storage conditions. It gives suggestions for how pharmacists and pharmacy staff can monitor PrEP adherence...
Module 8
Site Planning
July 2017
Module 8: Site planning. This module is for people involved in organizing PrEP services at specific sites. It outlines the steps to be taken in planning a PrEP service and gives suggestions for personnel, infrastructure and commodities that could be considered...
Module 9
Strategic planning
July 2017
Module 9: Strategic planning. As WHO recommends offering PrEP to people at substantial HIV risk, this module offers public health guidance for policy-makers on how to prioritize services, in order to reac...
Module 10
Testing providers
July 2017
Module 10: Testing providers. This module is for people who provide testing services at PrEP sites and laboratories. It offers guidance in selecting testing services, including screening of individuals before PrEP is initiated and monitoring while they ar...
Module 12:
Adolescents and young adults
July 2018
Module 12: Adolescents and young adults. This module is for people who are interested in providing PrEP services to older adolescents and young adults who are at substantial risk for HIV. It ...
Module 1q
PrEP users
July 2017
Module 11: PrEP users. This module provides information for people who are interested in taking PrEP to reduce their risk of acquiring HIV and people who are already taking PrEP – to support them in their choi...
Participant Manual
February 2011
Edition 3.0
Tuberculosis (TB) is the leading cause of illness and death among people living with HIV. TB can be cured.
Guidelines for Diagnosing and Managing Disseminated Histoplasmosis among People Living with HIV
recommended
Histoplasmosis is a disease caused by the fungus Histoplasma capsulatum. This disease is highly endemic in some regions of North America, Central America, and South America and is also reported in certain countries of Asia and Africa. It often affects people with impaired immunity, including people ...
In the time of coronavirus disease (COVID-19), sex and drug use will continue, regardless of physical distancing orders and policies. People who previously met in community gathering venues such as bars and clubs may now meet in different sites, ones that are “hidden” or less accessible. This, i...
COVID-19 is a serious disease and all people living with HIV should take all recommended preventive measures to minimize exposure to, and prevent infection by, the virus that causes COVID-19. As in the general population, older people living with ... or people living with HIV with heart or lung problems may be at a higher risk of becoming infected with the virus and of suffering more serious symptoms.
July 2021. This publication brings together important clinical and programmatic updates produced by WHO since 2016 and provides comprehensive, evidence-informed recommendations and good practice statements within a public health, rights-based and person-centred approach.
These guidelines bring in...
MEDBOX Issue Brief no.18.
The MEDBOX team has compiled a new issue brief on the impact of COVID-19 on PLHIV HIV prevention programmes and treatment for this year's World AIDS Day on 1 December 2021.
Severe bacterial infections are a leading cause of morbidity and mortality among people with advanced HIV disease, after tuberculosis and cryptococcal disease. For countries to reach the end-AIDS targets for 2030, there is a need to establish a road...
The Greater Horn of Africa is experiencing one of the worst food insecurity situations in decades. It is estimated
that more than 37 million people are in Integrated Food Security Phase Classification (IPC)1 phase 3 or above and approximately 7 million children under the age of five are acutely mal...
Recency assays use one or more biomarkers to identify whether HIV infection in a person is recent (usually within a year or less) or longstanding. Recency assays have been used to estimate incidence in representative cross-sectional surveys and in e...
